+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

North Africa Non-Invasive Prenatal Testing Market, By Application, By End User, By Country - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • PDF Icon

    Report

  • 126 Pages
  • February 2022
  • Region: Africa
  • Coherent Market Insights Pvt Ltd.
  • ID: 5555931
Noninvasive prenatal testing (NIPT) is also known as noninvasive prenatal screening (NIPS). It is a procedure used to determine the chromosomal abnormalities or disorders of the fetus which generally occur due to missing or an extra copy (aneuploidy) of a chromosome. NIPT examines small DNA fragments which are circulating in the blood of pregnant woman. These small fragments are freely floating and hence are called cell-free DNA. NIPT is carried out for the detection of trisomy 18, trisomy 13, Down syndrome, and missing or extra copies of X and Y chromosomes. NIPT is found to be useful during the COVID-19 pandemic situation to avoid the risk of infection. The potential to isolate fetal DNA and fetal cells from maternal blood during pregnancy has revealed exciting opportunities for upgraded noninvasive prenatal testing (NIPT).





Market Dynamics


The strong focus of key players on entering the North African market, and increasing awareness about the adoption of non-invasive prenatal testing are the major factors that are expected to drive the growth of North Africa non-invasive prenatal testing market over the forecast period.

For instance, according to the data published by National Library of Medicine in May 2020, twenty five studies in 9 sub-Saharan African countries manifested that the prevalence of birth defects was 20.40 per 1,000 births.

Moreover, in March 2019, Yourgene Health Plc, an international molecular diagnostics group, arranged an event in Egypt to increase the awareness of IONA test, a non-invasive prenatal DNA test performed for Down syndrome.

Key features of the study:

  • This report provides an in-depth analysis of North Africa non-invasive prenatal testing market, market size (US$ Mn.), and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in North Africa non-invasive prenatal testing market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Illumina, Inc., Eurofins Scientific, PerkinElmer, Inc., F. Hoffmann-La Roche AG, Natera, Inc., Yourgene Health Plc, Laboratory Corporation of America Holdings (LabCorp), BGI Group, Quest Diagnostics Incorporated
  • Insights from this report would allow marketers and the management authorities of companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • North Africa non-invasive prenatal testing market report caters to various stakeholders in this industry, including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the

Detailed Segmentation:


North Africa Non-invasive Prenatal Testing Market, By Application:

  • Trisomy
  • Microdeletion Syndrome
  • Sex Chromosome Abnormalities
  • Others

North Africa Non-invasive Prenatal Testing Market, By End User:

  • Hospitals
  • Diagnostic Centers & Independent Laboratories

North Africa Non-invasive Prenatal Testing Market, By Country:

  • Egypt
  • Algeria
  • Morocco
  • Rest of North Africa

Company Profiles

  • Illumina, Inc.
  • Company Overview
  • Material Portfolio
  • Financial Performance
  • Key Highlights
  • Market Strategies
  • Eurofins Scientific
  • PerkinElmer, Inc.
  • Hoffmann-La Roche AG
  • Natera, Inc.
  • Yourgene Health Plc
  • Laboratory Corporation of America Holdings (LabCorp)
  • BGI Group
  • Quest Diagnostics Incorporated
Frequently Asked Questions about the North African Non-Invasive Prenatal Testing Market

What is the estimated value of the North African Non-Invasive Prenatal Testing Market?

The North African Non-Invasive Prenatal Testing Market was estimated to be valued at $2796 Million in 2021.

What is the growth rate of the North African Non-Invasive Prenatal Testing Market?

The growth rate of the North African Non-Invasive Prenatal Testing Market is 7.9%, with an estimated value of $4759 Million by 2028.

What is the forecasted size of the North African Non-Invasive Prenatal Testing Market?

The North African Non-Invasive Prenatal Testing Market is estimated to be worth $4759 Million by 2028.

Who are the key companies in the North African Non-Invasive Prenatal Testing Market?

Key companies in the North African Non-Invasive Prenatal Testing Market include Illumina, Inc., Eurofins Scientific, PerkinElmer, Inc., Hoffmann, La Roche AG, Natera, Inc., Yourgene Health Plc, Laboratory Corporation of America Holdings (LabCorp) and Quest Diagnostics Incorporated.

Table of Contents

1. Research Objectives and Assumptions
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Application
  • Market Snippet, By End User
  • Market Snippet, By Country
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Mergers & Acquisitions, Collaborations & Partnerships
  • Product Approval and Launch
  • Technology Evolution
  • Ethical Concerns
  • PEST Analysis
  • Epidemiology

4. North Africa Non-invasive Prenatal Testing Market - Impact of Coronavirus (COVID-19) Pandemic
  • Economic Impact
  • Impact on Clinical Trials and Drug Development
  • Government Initiatives

5. North Africa Non-invasive Prenatal Testing Market, By Application, 2021 - 2028, (US$ Mn.)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Trisomy
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Microdeletion Syndrome
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Sex Chromosome Abnormalities
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)

6. North Africa Non-invasive Prenatal Testing Market, By End User, 2021 - 2028, (US$ Mn.)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018 - 2028
  • Segment Trends
  • Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)
  • Diagnostic Centers & Independent Laboratories
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn.)

7. North Africa Non-invasive Prenatal Testing Market, By Country, 2021 - 2028, (US$ Mn.)
  • Introduction
  • Market Share Analysis, By Region, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, For Regions, 2018-2028
  • Egypt
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn.)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn.)
  • Algeria
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn.)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn.)
  • (US$ Mn.)
  • Morocco
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn.)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn.)
  • Rest of North Africa
  • Market Size and Forecast, By Application, 2017 - 2028, (US$ Mn.)
  • Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn.)

8. Competitive Landscape
  • Heat Map Analysis
  • Market Share Analysis
  • Quest Diagnostics Incorporated
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Illumina, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Eurofins Scientific
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • PerkinElmer, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • F. Hoffmann-La Roche AG
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Natera, Inc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Yourgene Health plc.
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Laboratory Corporation of America Holdings (LabCorp)
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • BGI Group
  • Company Overview
  • Product Portfolio
  • Financial Overview
  • Key Highlights
  • Market Strategies
  • Analyst Views

9. Section
  • References
  • Research Methodology
  • About the publisher and Sales Contact

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Illumina, Inc.
  • Eurofins Scientific
  • PerkinElmer, Inc.
  • Hoffmann-La Roche AG
  • Natera, Inc.
  • Yourgene Health Plc
  • Laboratory Corporation of America Holdings (LabCorp)
  • BGI Group
  • Quest Diagnostics Incorporated